PanAgora Asset Management »

Abvc Biopharma shares owned by PanAgora Asset Management

Quarter-by-quarter ownership of Abvc Biopharma (ABVC) shares owned by PanAgora Asset Management from 13F filings

Historical chart of PanAgora Asset Management investment in Abvc Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Abvc Biopharma held by PanAgora Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abvc Biopharma by PanAgora Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $58k 37k 1.58

More positions owned by PanAgora Asset Management

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Inc-cl A Common (GOOGL)
Amazon.com Common (AMZN)
Broadcom Common (AVGO)
Alphabet Inc-cl C Common (GOOG)
Micron Technology Common (MU)
Advanced Micro Devices Common (AMD)
Meta Platforms Inc-class A Common (META)
Eli Lilly & Co Common (LLY)
Tesla Common (TSLA)
Lam Research Corp Common (LRCX)
General Electric Common (GE)
Bank Of America Corp Common (BAC)

View all positions for PanAgora Asset Management

Top funds holding Abvc Biopharma

Geode Capital Management
Vanguard Capital Management
Vanguard Fiduciary Trust
Renaissance Technologies
State Street Corporation
BlackRock
PanAgora Asset Management
Northern Trust
Two Sigma Securities
Dimensional Fund Advisors
Jane Street
Squarepoint Ops
Tower Research Capital
UBS Group
LifeSteps Financial

View all funds holding Abvc Biopharma